Latest Capital Management News

Shine Justice Ltd reported a modest 2.3% revenue increase to $209.2 million for FY26, alongside a striking 1,578% jump in net profit after tax to $9.6 million. The company declared a fully franked final dividend of 2.5 cents per share, signalling confidence amid ongoing investments in technology and international expansion.

Elevra Lithium posted a $44 million profit in FY26 after merging Sayona Mining and Piedmont Lithium, overcoming temporary mining challenges and securing full funding for the North American Lithium expansion.

Air New Zealand reported a $242 million net loss for FY2026, hit by soaring fuel prices and multi-year engine issues despite revenue growth and operational gains.

Sky Network Television Limited posted a robust FY26 with 9% revenue growth, a 45% dividend increase, and secured major sports rights through 2034, underpinned by the integration of Sky Free.

Channel Infrastructure NZ Limited reported a 47% rise in net profit for H1 2026, driven by expanded fuel storage capacity and upgraded EBITDA guidance, while declaring a 16% higher interim dividend.

PRL Global Ltd (ASX: PRG) reported a 52.5% jump in revenue to $2.26 billion for FY2026, alongside a 26.1% rise in net profit after tax. The company declared a higher final dividend of 3 cents per share, reflecting improved earnings despite a dip in total comprehensive income.

Wiseway Group delivered 10.1% revenue growth to $205.6 million in FY26, led by a 22.2% surge in its eCommerce Solutions division, while maintaining EBITDA margins amid cost discipline. The Group declared a fully franked final dividend of 0.6 cents per share.

Revolution Private Credit Income Trust (ASX: REV) posted a 6.25% net return for its inaugural period, outperforming its benchmark, and executed an on-market buy-back worth $23 million.

Kapstream Investment Trust (ASX:KIT) reported a $3.031 million profit and a 1.48% net return for its inaugural period ending June 2026, underperforming its benchmark but completing a 5% unit buy-back post-period.

Beonic Limited grew revenue by 5.2% to $23.3 million in FY26, halving its loss and achieving positive operating cash flow, underpinned by a landmark Moroccan airport contract and product innovation.

Actinogen Medical reported a $15.38 million loss for FY2026 while progressing its lead Alzheimer's drug Xanamem toward pivotal trial results expected this November. The company secured regulatory alignment and strengthened its cash position to fund operations through mid-2027.

Transmetro Corporation lifted its net profit after tax by nearly 50% to $4.489 million for FY26, driven by a 10.4% revenue increase and a 23.4% jump in EBITDA. The hospitality operator also raised its fully franked final dividend to 6 cents per share.